Skip to main content
eScholarship
Open Access Publications from the University of California

Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria.

  • Author(s): Dubois, Bruno
  • Hampel, Harald
  • Feldman, Howard H
  • Scheltens, Philip
  • Aisen, Paul
  • Andrieu, Sandrine
  • Bakardjian, Hovagim
  • Benali, Habib
  • Bertram, Lars
  • Blennow, Kaj
  • Broich, Karl
  • Cavedo, Enrica
  • Crutch, Sebastian
  • Dartigues, Jean-François
  • Duyckaerts, Charles
  • Epelbaum, Stéphane
  • Frisoni, Giovanni B
  • Gauthier, Serge
  • Genthon, Remy
  • Gouw, Alida A
  • Habert, Marie-Odile
  • Holtzman, David M
  • Kivipelto, Miia
  • Lista, Simone
  • Molinuevo, José-Luis
  • O'Bryant, Sid E
  • Rabinovici, Gil D
  • Rowe, Christopher
  • Salloway, Stephen
  • Schneider, Lon S
  • Sperling, Reisa
  • Teichmann, Marc
  • Carrillo, Maria C
  • Cummings, Jeffrey
  • Jack, Cliff R
  • Proceedings of the Meeting of the International Working Group (IWG) and the American Alzheimer's Association on “The Preclinical State of AD”; July 23, 2015; Washington DC, USA
  • Proceedings of the Meeting of the International Working Group (IWG) and the American Alzheimer's Association on “The Preclinical State of AD”; July 23, 2015; Washington DC, USA
  • et al.

Published Web Location

https://www.ncbi.nlm.nih.gov/pubmed/27012484
No data is associated with this publication.
Abstract

During the past decade, a conceptual shift occurred in the field of Alzheimer's disease (AD) considering the disease as a continuum. Thanks to evolving biomarker research and substantial discoveries, it is now possible to identify the disease even at the preclinical stage before the occurrence of the first clinical symptoms. This preclinical stage of AD has become a major research focus as the field postulates that early intervention may offer the best chance of therapeutic success. To date, very little evidence is established on this "silent" stage of the disease. A clarification is needed about the definitions and lexicon, the limits, the natural history, the markers of progression, and the ethical consequence of detecting the disease at this asymptomatic stage. This article is aimed at addressing all the different issues by providing for each of them an updated review of the literature and evidence, with practical recommendations.

Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.

Item not freely available? Link broken?
Report a problem accessing this item